ARCHIVES

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

Sharfstein To Leave FDA

January 7, 2011

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Funding Opportunities

September 6, 2002

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014